12.38
price down icon4.81%   -0.625
after-market After Hours: 16.14 3.765 +30.42%
loading

Anaptysbio Inc Stock (ANAB) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
20.28%
7.179
9.005 3.318 3.46 1.374
Operating Expenses
3.44%
49.38
51.14 41.05 43.60 45.77
Benefits Costs and Expenses
100.00%
-
180.78 - - -
Costs And Expenses
1.93%
49.38
50.35 41.05 43.60 45.77
Operating Income/Loss
0.16%
-42.20
-42.13 -37.73 -40.14 -44.40
Nonoperating Income/Loss
2,069%
-1.735
-0.08 0.424 0.298 0.146
Income/Loss From Continuing Operations Before Tax
104.18%
7.179
-171.78 3.318 -39.84 -44.26
Income/Loss From Continuing Operations After Tax
4.09%
-43.94
-42.21 -37.31 -39.84 -44.26
Net Income/Loss
4.09%
-43.94
-42.21 -37.31 -39.84 -44.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23,610%
26.80
-0.114 26.55 26.63 27.95
Diluted Average Shares
23,610%
26.80
-0.114 26.55 26.63 27.95
Basic Earnings Per Share
3.14%
-1.64
-1.59 -1.41 -1.50 -1.58
Diluted Earnings Per Share
3.14%
-1.64
-1.59 -1.41 -1.50 -1.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):